ArticleMolecular pharmaceutics2015

A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection.

Jin Huk Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.